{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:38:25Z","timestamp":1793194705057,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013058","name":"Jiangsu Provincial Key Research and Development Program","doi-asserted-by":"publisher","award":["BG2025030"],"award-info":[{"award-number":["BG2025030"]}],"id":[{"id":"10.13039\/501100013058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013254","name":"National College Students Innovation and Entrepreneurship Training Program","doi-asserted-by":"publisher","award":["202410315094Y"],"award-info":[{"award-number":["202410315094Y"]}],"id":[{"id":"10.13039\/501100013254","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U24A20785"],"award-info":[{"award-number":["U24A20785"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2024-19-12"],"award-info":[{"award-number":["320.6750.2024-19-12"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.phymed.2026.158749","type":"journal-article","created":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:26:48Z","timestamp":1787495208000},"page":"158749","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Arglabin targets a non-canonical NLRP3\/CCR2 axis to suppress MDSC infiltration and potentiates anti-PD-1 immunotherapy in hepatocellular carcinoma"],"prefix":"10.1016","volume":"161","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1361-7953","authenticated-orcid":false,"given":"Di","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyuan","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3219-1418","authenticated-orcid":false,"given":"Jiayi","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuzhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Siyi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlong","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhua","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3148-3370","authenticated-orcid":false,"given":"Jian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3231-2829","authenticated-orcid":false,"given":"Lihong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2026.158749_bib0001","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1161\/CIRCULATIONAHA.114.013730","article-title":"Anti-inflammatory and antiatherogenic effects of the NLRP3 inflammasome inhibitor arglabin in ApoE2.Ki mice fed a high-fat diet","volume":"131","author":"Abderrazak","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.phymed.2026.158749_bib0002","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41423-025-01281-y","article-title":"The intrinsic expression of NLRP3 in Th17 cells promotes their protumor activity and conversion into Tregs","volume":"22","author":"Accogli","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.phymed.2026.158749_bib0003","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.fitote.2015.11.018","article-title":"Chemical modification of arglabin and biological activity of its new derivatives","volume":"110","author":"Adekenov","year":"2016","journal-title":"Fitoterapia"},{"key":"10.1016\/j.phymed.2026.158749_bib0004","article-title":"Atezolizumab\/bevacizumab or lenvatinib in hepatocellular carcinoma: Multicenter real-world study with focus on bleeding and thromboembolic events","volume":"6","author":"Ben","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.phymed.2026.158749_bib0005","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.immuni.2025.04.027","article-title":"Glycosylation-driven programs coordinate immunoregulatory and pro-angiogenic functions of myeloid-derived suppressor cells","volume":"58","author":"Blidner","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.phymed.2026.158749_bib0006","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.phymed.2026.158749_bib0007","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/ni.3202","article-title":"The receptor NLRP3 is a transcriptional regulator of TH2 differentiation","volume":"16","author":"Bruchard","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.phymed.2026.158749_bib0008","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1007\/s00018-017-2720-9","article-title":"Blockage of the NLRP3 inflammasome by MCC950 improves anti-tumor immune responses in head and neck squamous cell carcinoma","volume":"75","author":"Chen","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.phymed.2026.158749_bib0009","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jare.2024.01.028","article-title":"Dehydrocostus lactone suppresses gastric cancer progression by targeting ACLY to inhibit fatty acid synthesis and autophagic flux","volume":"67","author":"Chen","year":"2025","journal-title":"J Adv Res"},{"key":"10.1016\/j.phymed.2026.158749_bib0010","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/hep.28655","article-title":"Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26","volume":"64","author":"Chiu","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2026.158749_bib0011","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.phymed.2026.158749_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108512","article-title":"NLRP3 promotes immune escape by regulating immune checkpoints: A pan-cancer analysis","volume":"104","author":"Ding","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.phymed.2026.158749_bib0013","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-1-0716-1060-2_10","article-title":"In Vitro Generation of Murine Myeloid-Derived Suppressor Cells, Analysis of Markers, Developmental Commitment, and Function","volume":"2236","author":"Eckert","year":"2021","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.phymed.2026.158749_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113873","article-title":"Arglabin, an EGFR receptor tyrosine kinase inhibitor, suppresses proliferation and induces apoptosis in prostate cancer cells","volume":"156","author":"El Gaafary","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.phymed.2026.158749_bib0015","doi-asserted-by":"crossref","DOI":"10.1038\/srep11664","article-title":"CCR2 inhibition sequesters multiple subsets of leukocytes in the bone marrow","volume":"5","author":"Fujimura","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.phymed.2026.158749_bib0016","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41590-024-02068-5","article-title":"The lactate receptor HCAR1 drives the recruitment of immunosuppressive PMN-MDSCs in colorectal cancer","volume":"26","author":"He","year":"2025","journal-title":"Nat Immunol"},{"key":"10.1016\/j.phymed.2026.158749_bib0017","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12943-024-02208-3","article-title":"Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy","volume":"24","author":"He","year":"2025","journal-title":"Mol Cancer"},{"key":"10.1016\/j.phymed.2026.158749_bib0018","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/gutjnl-2015-310514","article-title":"Targeting of tumour-infiltrating macrophages via CCL2\/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma","volume":"66","author":"Li","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.phymed.2026.158749_bib0019","article-title":"NLRP3\/IL-1beta induced myeloid-derived suppressor cells recruitment and PD-L1 upregulation promotes oxaliplatin resistance of hepatocellular carcinoma","volume":"4","author":"Liu","year":"2023","journal-title":"MedComm (2020)"},{"key":"10.1016\/j.phymed.2026.158749_bib0020","first-page":"13","article-title":"Targeting the NLRP3 inflammasome abrogates cardiotoxicity of immune checkpoint blockers","author":"Lu","year":"2025","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.phymed.2026.158749_bib0021","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/all.15164","article-title":"The NLRP3 inflammasome inhibitor, OLT1177((R)), ameliorates experimental allergic asthma in mice","volume":"77","author":"Lunding","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.phymed.2026.158749_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2021.100937","article-title":"A protocol for isolation of primary human immune cells from the liver and mesenteric white adipose tissue biopsies","volume":"2","author":"Moreno-Fernandez","year":"2021","journal-title":"STAR Protoc"},{"key":"10.1016\/j.phymed.2026.158749_bib0023","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S1470-2045(16)00078-4","article-title":"Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial","volume":"17","author":"Nywening","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.phymed.2026.158749_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107451","volume":"189","author":"Paz-Ares","year":"2024","journal-title":"Lung Cancer"},{"key":"10.1016\/j.phymed.2026.158749_bib0025","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s10637-012-9869-8","article-title":"Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer","volume":"31","author":"Pienta","year":"2013","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.phymed.2026.158749_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115318","article-title":"The role of CCL2\/CCR2 axis in cancer and inflammation: The next frontier in nanomedicine","volume":"209","author":"Pozzi","year":"2024","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.phymed.2026.158749_bib0027","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jhep.2023.03.003","article-title":"Combination immunotherapy for hepatocellular carcinoma","volume":"79","author":"Rimassa","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.phymed.2026.158749_bib0028","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41590-018-0044-z","article-title":"The immunology of hepatocellular carcinoma","volume":"19","author":"Ringelhan","year":"2018","journal-title":"Nat Immunol"},{"key":"10.1016\/j.phymed.2026.158749_bib0029","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00280-013-2099-8","article-title":"A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors","volume":"71","author":"Sandhu","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.phymed.2026.158749_bib0030","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/s41423-025-01308-4","article-title":"Immune microenvironment in hepatocellular carcinoma: from pathogenesis to immunotherapy","volume":"22","author":"Seyhan","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.phymed.2026.158749_bib0031","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12964-023-01235-9","article-title":"Divergent functions of NLRP3 inflammasomes in cancer: a review","volume":"21","author":"Shadab","year":"2023","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.phymed.2026.158749_bib0032","first-page":"173","article-title":"Arglabin-DMA, a plant derived sesquiterpene, inhibits farnesyltransferase","volume":"8","author":"Shaikenov","year":"2001","journal-title":"Oncol Rep"},{"key":"10.1016\/j.phymed.2026.158749_bib0033","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri3070","article-title":"Monocyte recruitment during infection and inflammation","volume":"11","author":"Shi","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.phymed.2026.158749_bib0034","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1158\/1535-7163.MCT-16-0124","article-title":"Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model","volume":"16","author":"Teng","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.phymed.2026.158749_bib0035","first-page":"118","article-title":"Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion","author":"Tengesdal","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.phymed.2026.158749_bib0036","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12943-022-01662-1","article-title":"Costunolide is a dual inhibitor of MEK1 and AKT1\/2 that overcomes osimertinib resistance in lung cancer","volume":"21","author":"Tian","year":"2022","journal-title":"Mol Cancer"},{"key":"10.1016\/j.phymed.2026.158749_bib0037","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.it.2020.04.004","article-title":"Opportunities for Small Molecules in Cancer Immunotherapy","volume":"41","author":"van der Zanden","year":"2020","journal-title":"Trends Immunol"},{"key":"10.1016\/j.phymed.2026.158749_bib0038","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccr.2012.05.023","article-title":"Endothelial CCR2 signaling induced by colon carcinoma cells enables extravasation via the JAK2-Stat5 and p38MAPK pathway","volume":"22","author":"Wolf","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.phymed.2026.158749_bib0039","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jhep.2023.02.036","article-title":"FGF19\/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2","volume":"79","author":"Xie","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.phymed.2026.158749_bib0040","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cytogfr.2020.12.003","article-title":"Chemokine networks modulating natural killer cell trafficking to solid tumors","volume":"59","author":"Yao","year":"2021","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.phymed.2026.158749_bib0041","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/s41419-021-04159-9","article-title":"A novel function of NLRP3 independent of inflammasome as a key transcription factor of IL-33 in epithelial cells of atopic dermatitis","volume":"12","author":"Zheng","year":"2021","journal-title":"Cell Death Dis"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326009803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326009803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:13:26Z","timestamp":1793193206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711326009803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":41,"alternative-id":["S0944711326009803"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158749","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Arglabin targets a non-canonical NLRP3\/CCR2 axis to suppress MDSC infiltration and potentiates anti-PD-1 immunotherapy in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158749","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"158749"}}